Articles related to MEDICAL UNIVERSITY PRESS

In this video, Dr. Robert Vonderheide, the Director of the Abramson Cancer Center at Penn Medicine, discusses cancer interception, an approach to cancer treatment that involves identifying and treating pre-cancerous cells before they develop into tumors. Dr. Vonderheide explains that cancer interception involves using genomic sequencing to identify cells that are at high risk of developing into cancer and then using drugs or other treatments to kill these cells before they become cancerous. He notes that cancer interception has the potential to be a highly effective form of cancer treatment, but that it requires a collaborative approach between researchers, clinicians, and patients. Dr. Vonderheide also discusses the role of immunotherapy in cancer interception and the challenges associated with developing effective interception strategies for different types of cancer.

A look into the results of a few patients that took part in a phase 1/2 trial at the Icahn School of Medicine at Mount Sinai in New York City: a woman who had breast cancer for 23 years and gone through 12 lines of therapy and a man with non-Hodgkin lymphoma (NHL) since 2017. Both showed complete response to the novel vaccine.

The development of effective new therapies has been challenging. This discovery of calcium signaling as a central abnormality in schizophrenia neurons is an exciting new finding, since available antipsychotics treat only positive symptoms and are not effective for all patients.

Kathryn Hufmyer, MD, and Linda Suleiman, MD, will focus on incorporating artificial intelligence, creative education models, and interprofessional education and continue to focus on diversity, equity, and inclusion.